MOFCOM's Stance On Novartis/Alcon

Law360, New York (September 9, 2010, 12:22 PM EDT) -- On Aug. 1, 2010, China's Anti-Monopoly Law (AML) turned two. The Ministry of Commerce (MOFCOM) — the agency in charge of merger control in China — celebrated the anniversary with a bang: on Aug. 13, it cleared the acquisition by life sciences company Novartis of a majority stake in rival Alcon, but only subject to conditions.

Almost 10 months have passed since the last time MOFCOM imposed conditions on a merger clearance decision. The Novartis/Alcon case is only the sixth MOFCOM decision involving remedies, but already...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.